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Chapter 4
Management accounting and 
efficiency in health services: the 
foundational role of cost analysis
Christopher S. Chapman, Anja Kern, Aziza Laguecir and Wilm Quentin
4.1 Introduction
Efficiency measurement is concerned with measuring and analysing inputs in 
relation to outputs or vice versa. Management accounting offers a broad set of 
tools and techniques for measuring and managing many aspects of this challenge. 
Rising health care costs, driven by population growth, demographic shifts and 
advances in medical technology, put the focus on cost analysis and management 
because cost information underpins decisions on resource allocation and effective-
ness at system and organizational levels for providers, purchasers and regulators 
globally. In this chapter, we focus on costing because cost information feeds into 
many other common management accounting practices, such as tariff setting, 
targeted cost improvement plans, benchmarking, budgeting, service redesign 
and performance management.
The peculiarities of the nature of health care as an area of activity have very spe-
cific implications for the scope and nature of cost accounting. First, health care 
in most countries is a heavily regulated sector, and this regulation has a direct 
impact on definitions of costing, that is, how costing is carried out, including 
the calculation itself, but also linked concepts such as the kind of cost object that 
becomes a focus for analysis. For example, regulations on payment of hospitals 
on the basis of DRGs has made the DRG the major cost object in the acute 
sector, in turn having an impact on the costing calculation and medical practice 
(Chapman, Kern & Laguecir, 2014).
A second impact of the nature of health care on costing practice derives from the 
fact that treatment must often be adjusted for each patient; therefore, patient-
level costing should account for differences between patients. However, the share 
of total cost that can be directly attributed to patients is relatively small. Studies 
suggest that the direct variable costs that can be directly influenced by physi-
cians are around 42% (Taheri, Butz & Greenfield, 2000) with 58% of fixed and 
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indirect costs1 being out of reach of physicians’ responsibility. Similarly, studies 
on hospital cost structure have emphasized the high proportion of fixed costs in 
this setting, reaching 65%, thus making it difficult for front-line staff to actually 
manage costs (or more precisely, short-run cash flows) at patient level (Roberts 
et al., 1999). A volume-based allocation of indirect costs is not appropriate for 
supporting cost management at the patient-level, which instead requires an 
activity-based approach. An activity-based approach also allows linking costs 
with health outcomes in a meaningful way (Kaplan & Porter, 2011).
A third impact arises from the fact that there is high pressure to improve the 
efficiency of health care services while keeping quality at the same level, the aim 
being the generation of more benefits from the current levels of spending. As 
a result, the number of users for costing data has increased, now ranging from 
government and regulators at national or regional level, to health care professions, 
insurers, health care providers, patients and the general public. This unusually 
wide range of users makes it difficult to adjust the nature of calculations to the 
potentially different purposes and interests of these users (Smith et al., 2008).
Perhaps this diversity helps to explain why, despite a growth in the reach and 
complexity of costing in recent years, progress has been hampered by a tendency 
towards a lack of conceptual clarity over the costing methodologies appropriate 
to particular kinds of purposes and decision-making objectives (Chapman, Kern 
& Laguecir, 2014). Recent developments have shown far greater attention to 
the detailed task of costing. Costing has been recognized by policymakers as the 
key for improving the quality of evaluation of health care services. The kind of 
costing in place does not only directly influence the accuracy of the tariff, but 
also how health care can be managed (Monitor, 2014a). The rapid development 
of patient-level information and costing systems also shows the recognition that 
cost data must sit alongside other patient information (including comorbidities 
and outcomes). Making this link helps raise the stakes of analysis to include 
effectiveness beyond efficiency (Kaplan & Porter, 2011).
However, before costing can live up to such expectations, we must first address 
the widely noted concern over the variability and quality of existing cost infor-
mation (Busse, Schreyögg & Smith, 2008; Busse et al., 2011; Chapman et al., 
2013; Monitor, 2006, 2013; Northcott & Llewellyn 2004). In fact, many coun-
tries find it difficult to produce high-quality costing data (Busse, Schreyögg & 
Smith, 2008; Busse et al., 2011). Analysis of health care costs across countries 
has revealed that the cost structure behind a certain procedure or treatment varies 
significantly from one country to another and between providers within countries.
1 In this article the terms indirect costs and overhead costs are used interchangeably. We argue that it is 
not the location where costs are incurred (e.g. medical or administrative areas) that is decisive for cost 
system design, but rather their relation to cost objects. The relation of costs to the cost object determines 
if costs are direct or indirect costs.
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Table 4.1 shows the analysis of costs for a single procedure (AMI) across countries 
as analysed by Tiemann and colleagues (2008). Particularly notable variances 
are ward costs, which vary between 9.76% in Denmark and 74.55% in the 
Netherlands, with corresponding changes to the level of overheads reported in each 
of these countries. While variations in medical practices across countries can be at 
the origin of differences, there are significant differences caused by variations in 
costing methods and conventions as to what is classed in which category of cost.
Poor-quality cost data – whether in terms of unexplained sources of variance or 
inappropriate disguising of variance through excessive reliance on averages – are 
a threat to the delivery of efficient and effective health care. Poor-quality data will 
not be used in decision-making (or will not be effective if used) while resources will 
be consumed in producing it. Towards the end of the chapter we offer a detailed 
discussion of the kinds of efficiency decisions that high-quality cost data might 
inform. However, given the centrality of cost system design to the production of 
data that can be used in decision-making, we will address this crucial issue first.
Table 4.1 Costs in different cost categories for AMI
  England France Germany Hungary Italy Netherlands Poland Spain Denmarka
Diagnostic 
procedures
€345.74 €446.79 €296.84 €70.43 €316.97 €349.71 €138.19 €349.52 €349.52
As % of total costs 6.90% 7.55% 10.36% 17.79% 4.25% 6.25% 13.47% 18.78% 7.53%
Normal ward/catheter lab              
As % of total costs 31.40% 46.45% 58.63% 35.34% 41.48% 74.66% 48.14% 53.67% 9.76%
 Physician €217.20 €614.43 €356.80 €67.95 €406.04 €316.86 €212.46 €167.67 €76.79
 Nursing €644.79 €683.56 €782.29 €71.98 €375.10 €2121.49 €210.42 €831.09 €117.67
 Others €90.51 €136.77 €50.32 b €22.18 €209.02 €70.92 b €34.54
 Materials €621.65 €1313.46 €491.26 b €2286.91 €1533.33 b b €224.17
Drugs €1556.36 €1347.82 €164.97 €89.20 €696.36 €424.28 €189.26 €29.83 €10.78
As % of total costs 31.04% 22.78% 5.76% 22.53% 9.35% 7.58% 18.45% 1.60% 0.23%
Overheads €1537.39 €1373.62 €723.89 €96.40 €3346.66 €644.61 €204.52 €482.91 €3829.73
As % of total costs 30.66% 23.22% 25.25% 24.35% 44.92% 11.51% 19.94% 25.95% 82.48%
Total cost €5013.64 €5916.45 €2866.36 €395.97 €7450.22 €5599.30 €1025.76 €1861.02 €4643.20
Total costs  
(PPP-adjusted)
€4646.51 €5507.93 €2723.07 €657.14 €7251.03 €5322.83 €1863.61 €2050.18 €3455.00
Reimbursement €4351.00 €5731.06 €3113.96 €808.86 €7574.58 €8722.00 €932.50 c c
Profit -€662.64 -€185.39 €247.60 €412.89 €124.36 €3122.70 -€93.26 c c
Profit margin -13.22% -3.13% 8.64% 104.27% 1.67% 55.77% -9.09% c c
Sources: Table II in Tiemann (2008).
Notes: aPartly subsumed in overhead costs. bSubsumed in overhead costs. cNo data available. AMI = acute 
myocardial infarction; PPP = purchasing power parity.
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4.2 Analysing the challenge of cost system design
In thinking about the fundamental steps required in attaching the elements of 
organizational cost to a particular cost object (such as a patient), there are three 
basic analytical steps that must be taken:
1. The costing system needs to identify and group together the costs of 
the various types of resources that the organization has (for example, 
clinical staff, drugs, premises).
2. Resource costs need to be grouped into cost pools (based around 
departments or other managerial cost centres, or activities) for which 
choices are made as to the cost driver for the cost pool.
3. Costs have to be linked (showing more or less variability depending 
on the choices made) to the chosen cost object (for example, the 
patient, the service line, and so on).
Choices must be made as to the level of granularity in each of these three steps 
and there is no single universally best approach to making these choices. Partly 
this is a result of the many different purposes towards which cost data might be 
put (for example, price setting, cost management, resource allocation). Partly 
this is a result of the trade-off to be struck between rising costs as granularity 
increases set against the possibility of better decisions such granularity may or 
may not offer. In considering this, it is vital to understand that granularity is 
not simply a function of the granularity of the cost object (step 3), but also of 
granularity choices made in the first two steps. Also, while we have separated 
these steps for the purposes of conceptual clarity, in practice many of these deci-
sions are interdependent and taken simultaneously.
4.2.1  Step 1: determining the granularity of costs at resource level
Based on the chart of accounts (that is, a listing of the accounts found in the 
general ledger of an organization), costs are most typically grouped according to 
the kind of costs they represent, such as salaries or materials. The way the chart 
of accounts is constructed significantly influences the detail that is available for 
costing. For example, instead of simply dealing with salaries as an overarching 
category, there can be a detailed breakdown of the salaries of nurses, clinicians, 
technicians, administrative staff, and so on. In addition, the chart of accounts 
may allow for the separation of salaries for certain grade levels.
The structure of the chart of accounts and its details therefore greatly influence 
the detail and nature of costs that are readily available for the costing calculation 
undertaken in steps 2 and 3. Further detail can always be added to that made 
available through the chart of accounts if detailed ad hoc analysis is undertaken, 
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but this is costly to produce and maintain accurately, and so cost system design 
relies heavily on the structure of the chart of accounts. This is not always to its 
benefit given that often the chart of accounts is structured with external financial 
reporting in mind (Johnson & Kaplan, 1987).
With this concern in mind, it is quite common for the chart of accounts to 
introduce relevant notions of cost behaviour in terms of differentiating between 
fixed (costs that do not change with the level of output) and variable (costs that 
change with the level of output) costs in relation to specific resources being 
mapped. This kind of distinction can feed into ad hoc analysis of marginal cost 
changes in relation to service redesign decisions and the application of a set 
of basic management accounting techniques comprising cost–volume–profit 
analysis. The strength of this framing of cost behaviour is that it quickly and 
easily allows the modelling of short-run cash flows, something that is both 
important and intuitively appealing as a matter of concern to a wide range of 
stakeholders.
The limitations of a fixed and variable framing of cost behaviour are particularly 
pressing in areas such as health care where a large proportion of cost is fixed. 
Such a framing can help bring about a relative inattention to fixed costs, even 
creating a sense that such costs are inevitable. However, even when attention 
is directed towards fixed costs, under such a framing the approach offers little 
support for capacity planning and management. Both of these factors can easily 
lead to a lack of control of fixed costs and inefficient use of them.
Management accounting offers the distinction between direct (costs that can 
be logically linked to a cost object) and indirect (costs that cannot) costs to 
address these limitations. In relation to fixed and variable costs, a variable cost 
is in principle direct. A fixed cost may or may not be. The fixed cash flow cost of 
a clinician’s salary can still be direct in relation to the time spent with different 
patients, for example. However, the fixed cash flow cost of premises is indirect.
DRG tariff structures are often based on the full cost of specific treatments. Full 
cost is made up of the direct costs of the treatment and an appropriate share of 
indirect costs, such that ultimately if all reported treatment costs are added up, 
the total is the total cost of the provider organization. The central choice to be 
made is how to determine what an appropriate share of indirect costs is. There 
are two main alternatives here: volume-based allocation and an activity-based 
approach.
Traditional volume-based absorption costing assumes that indirect costs are 
fixed and can be allocated identically to each service delivered. However, since 
an indirect cost cannot logically be linked to a cost object, volume-based alloca-
tion is inherently arbitrary and in principle incorrect. In terms of monitoring 
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short-run cash flows, this is not so damaging because the fixed cash flows are 
assumed to be largely unaffected by different output choices.
The problem with volume-related allocation (which an activity-based approach 
is designed to remedy) is that while the indirect costs are not related to volume, 
they are related to something. If the costing system does not reflect these actual 
relationships, then in the medium term there is a risk of promoting behaviours 
that will inadvertently increase overheads and short-run fixed cash flows. The 
central argument of activity-based costing is that traditional volume-based alloca-
tions systematically overvalue high-volume simple processes and systematically 
undervalue low-volume complex ones. As a result, such systems encourage more 
low-volume complex activities that in turn require greater overhead investments to 
handle the increased complexity. Thus, the risk with volume-related systems is that 
indirect costs will rise faster than the volume of services (Kaplan & Cooper, 1998).
While the choice between volume-based and activity-based analysis is most com-
monly thought of in relation to the next step (step 2), it is important to bear in 
mind that the relative ease of analysing activity costs depends on the structure 
and granularity of the chart of accounts.
4.2.2  Step 2: determining the granularity of cost pools and cost 
drivers
This step involves two related choices. The first choice involves the aggregation 
of resources identified in the chart of accounts into cost pools that form the basic 
structure of analysis in cost systems. The second choice involves the selection 
of a cost driver for the resulting cost pools that allows costs to be linked to the 
chosen cost object (step 3).
The conceptual challenge in terms of direct costs is not great, although captur-
ing the necessary data can be more difficult. The difficulties arise when dealing 
with indirect costs. In the health care sector, a distinction is often made between 
indirect costs linked to medical processes (for example, manager of the operating 
theatre) and overhead costs linked to the indirect costs of the administration 
(for example, chief executive officer of the hospital or central departments such 
as accounting, legal department, and so on). When we use the word indirect 
cost in this chapter, we refer to all non-direct costs because the choices for their 
treatment are conceptually the same in terms of the visibility of cost behaviour.
Take, for example, a figure for the overall cost of the finance department. This 
is an indirect cost in the sense that it is a cost whose behaviour we do not easily 
understand at the patient level and so we are challenged when it comes to choosing 
an appropriate cost driver. This difficulty arises because the costs of the finance 
department are an aggregation of many different resource costs (for example, 
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payroll costs of accounting staff, office costs to house them, utilities such as 
electricity, but also consumables such as paper and computers), which rise and 
fall in relation to many different factors. Such department-based aggregations 
are often a matter of practical convenience. As a department, there will likely 
be an annual budget that groups together all of these resource costs. In terms of 
authorizing spending, this is useful; however, this aggregation is not helpful for 
understanding cost behaviour.
By virtue of aggregating so many different kinds of costs into a single figure, 
there is no single cost driver that offers a clear reflection of what accounts for 
costs in the finance department. The volume of services offers an intuitive but 
noisy basis for analysis. At an aggregate level, it is plausible that more patients 
will to some extent lead to more finance department costs. As soon as we 
consider individual patients, however, it seems likely that individual patient 
consumption of finance department resources might vary considerably depend-
ing on many different factors, some of which will have nothing to do with 
patient behaviour.
The alternative to a volume-related allocation is an activity-based costing approach. 
This would reanalyse departmental costs, breaking them down into cost pools 
reflecting specific activities (for example, running the payroll, credit control). 
Once analysed in terms of activities, it becomes possible to understand what 
drives costs. For example, payroll costs likely depend more on the number of 
clinical staff than the number of patients (because staff/patient ratios might vary 
considerably across specialities) suggesting the need for a two-stage approach 
attributing payroll costs to clinicians first and then to patients. Credit control 
costs may also display significant differences between specialities depending on 
particular financing arrangements that may again have very little to do with 
patient numbers.
Credit control is another high-level activity. Depending on the nature of decisions 
to be taken, it might be appropriate to break it down into subactivities and to 
map resources yet in more detail. When it comes to the nature of the cost driver, 
again choices must be made about granularity. For example, we must decide 
whether it is sufficient to assume that credit control costs are driven by patient 
numbers in particular specialities, or whether a more granular analysis of hours 
spent on particular patient cases is appropriate as a cost driver.
As always, these decisions are a trade-off between the cost of collecting and 
analysing more granular data over the possibilities for making better decisions in 
light of it. The distinction between direct and indirect costs is not purely linked 
to the nature of costs, but also depends on this trade-off between the cost of 
understanding indirect cost behaviours such that they may be considered direct 
costs and the benefit of having such direct costs inform decision-making. For 
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example, drugs are in principle a direct cost, in that specific patients consume 
them. However, depending on the cost of a drug, the cost system may treat it 
as a direct or indirect cost. If the cost of a drug is relatively high (for example, 
a high-cost cancer treatment), it may be beneficial to attribute this cost directly 
to the particular patient. However, if a drug is less expensive (for example, a 
standard cancer treatment), its cost may be treated effectively as an indirect cost 
if the cost of analysis outweighs the possibilities of making better decisions on 
the basis of more refined information. The same choice must be made for staff 
costs (that is, should they be treated as direct or effectively indirect costs) and 
at what level of granularity.
In summary, activity-based costing is an approach to attribute resource costs (step 
1) to cost objects (step 3), where careful choices are made to link indirect costs 
to the specific activities that drive them. Activity-based costing is an alternative 
to volume-related allocation of indirect costs to cost objects (for example, divid-
ing costs across patient numbers). Volume-related allocation sacrifices precision 
for the sake of simplicity and reduced cost of measurement. In deciding how 
best to account for indirect costs, it is important to always consider the costs 
and benefits associated with collecting such data. The question to ask is: Does 
the effort to transform a particular block of overheads into direct costs through 
an analysis of activity pay back with regard to the decision-making benefits 
obtained from such efforts?
4.2.3  Step 3: determining the granularity of the chosen cost object
A costing system can always produce an estimate of the cost of a particular 
cost object (for example, patient episode, patient, service line, trust). However, 
depending on the approach taken in the previous steps, this estimate may 
more or less reflect reality. As such, this final step is potentially the least 
informative in terms of giving a useful indication of the granularity of a 
costing system, which in practice derives much more from choices made in 
the preceding two steps. A key matter in terms of granularity at this level 
arises more from the degree to which a particular cost represents an average 
across a particular level of cost object, or shows reliable variability between 
costs at that level.
This issue is often discussed with regard to top-down and bottom-up costing. 
Dividing total operating theatre costs by the number of patients to identify a 
cost attributable to an individual patient is a top-down approach. Aggregating 
the per-theatre minute costs to arrive at a total per-patient cost is a bottom-up 
approach that allows visibility of cost variation between patients. To rephrase 
this distinction, with words that make it more obvious how and why these dis-
tinctions matter: a top-down approach is a cheap way to produce average costs. 
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A bottom-up figure helps to reflect variability of resource consumption across 
particular cost objects, but it is more expensive to produce.2
The development of time-driven activity-based costing (TDABC) (Kaplan & 
Anderson, 2004) represents a development that can reduce the costs of more 
flexible and granular analysis using a bottom-up, activity-based approach. The 
first step is to work out the total cost of relevant resources required by a cost 
object and determine the level of practical capacity of the resources to provide 
services. Time in TDABC reflects the observation that for a surprisingly wide 
range of resources, this is an appropriate unit of capacity. The second step is to 
charge cost objects with their consumption of capacity at the per-unit cost of 
capacity worked out in the first step.
An advantage of TDABC is that it simplifies step 2 as undertaken in earlier 
activity-based costing systems. So, for example, an early activity-based costing 
system might have aggregated clinical staff costs as a resource (step 1). This would 
then be split across inpatient and outpatient activities based on consultant job 
plans (step 2). These costs would then be driven to patients in the inpatient and 
outpatient areas (step 3). A TDABC approach avoids the need to make a priori 
assumptions about the split in step 2. When dealing with the activity of people, 
this is particularly useful since their split across many activities can significantly 
and frequently vary. TDABC instead works out a per-minute cost of clinical 
staff time and then builds costs up from the assignment of that cost to minutes 
spent with inpatients and outpatients. Granularity at step 3 can then be easily 
adjusted by doing this using estimates, or standard minute rates per activity, or 
direct measurement depending on the importance of the information in terms 
of its capacity to inform useful decisions.
4.3 Demonstrating cost system design choices with two 
detailed examples
To place the various choices and distinctions discussed in the previous section 
within a more concrete context, next we analyse how these choices play out using 
two detailed examples chosen for their impact in terms of clinical and financial 
importance. First, we discuss how these cost system design choices impact on the 
analysis of costs in the operating theatre, and second how they have an impact on 
the analysis of property costs. The examples are based on observations of costing 
practices and national costing guidelines Germany and the United Kingdom.
2 Here, we use the terms volume-based and activity-based costing to distinguish two different kinds of 
treatments of indirect costs. In the literature, other distinctions that are often used synonymously can 
be found, for example, micro costing and bottom-up costing. These are used synonymously for activity-
based costing and macro costing, while top-down costing is often used as synonym for the volume-based 
allocation of costs.
Health system efficiency84
4.3.1 Tracing operating theatre costs to patients
The operating theatre in an acute care hospital represents a highly significant 
resource and location of clinical activity. As such, the way in which cost is traced 
to patients receiving treatment in operating theatres is a matter of considerable 
importance. As documented in Chapman & Kern (2010) and based on research 
in the United Kingdom, there is considerable variability to be found in terms of 
the sophistication of cost system design relating to activity in operating theatres.
The least granular level of cost modelling observed consisted of a single cost pool 
that assembled all resources assigned to the operating theatres (for example, space 
costs, clinical staff costs, consumables costs, and so on) with minutes in theatre 
as a cost driver applied to a single cost pool. This has been mapped out in Table 
4.2, which shows this very simple costing approach to operating theatres with 
resources on the horizontal axis (columns), activities on the vertical axis (rows), 
and the chosen cost driver at the intersection.
Table 4.2 A very simple costing approach for operating theatre activity
RESOURCES All costs
ACTIVITIES
All operating theatres Per-minute cost
This system gives a per-minute cost rate based on total cost and total minutes 
across all patients as applied to the minutes of a particular patient on the oper-
ating theatre register. The cost driver minutes seems activity-based and the cost 
object is the patient, so this may lead to the belief that this is a patient-level, 
activity-based approach to costing. However, the problem is that the choice of 
cost pools is not activity-based and there is a minimum possible granularity with 
regard to activity and resource analysis (although the cost driver shows at least 
more granularity than simply patient numbers would have given). Hence this 
cost calculation is closer to a volume-based then an activity-based approach.
At the next level of sophistication, we encountered an intermediate level of cost 
model granularity. This arose when providers had multiple operating theatres, and 
we found that individual theatres were often used for particular clinical speciali-
ties. This allowed for the construction of individual operating theatre cost pools 
that collected the various costs of the procedures undertaken in each particular 
theatre. As a result, the system could reflect the potentially very different costs 
for staff (for example, because of very different staffing levels for particular kinds 
of procedures) within different specialities resulting in different per-minute costs 
for the different operating theatres. We have mapped this approach in Table 4.3.
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Table 4.3 An elaboration of the very simple costing approach for operating 
theatre activity
RESOURCES All costs for theatre 1 All costs for theatre 2 All costs for theatre 3
ACTIVITIES
Operating 
theatre for 
speciality 1
Per-minute cost
Operating 
theatre for 
speciality 2
Per-minute cost
Operating 
theatre for 
speciality 3
Per-minute cost
As in the simple model, the cost object is the patient, and again there is little 
granularity at the resource level where all kinds of resources are grouped together. 
It is more granular than that seen in the previous model (Table 4.2) given that 
there is a cost centre-based grouping of resource costs. The lack of resource 
granularity makes it difficult to differentiate between resources like clinician 
time and nurse time, however. As such, when it comes to developing a more 
granular set of cost pools to map the resources onto, there is little to go on. And 
so we find a cost system that produces three separate cost-per-minute rates that 
can be traced to patients in the three different specialities. Overall however, the 
level of granularity is still very low.
At the most sophisticated level we encountered a cost system that distinguished 
resources and activities at a far more granular level. Such an approach also mirrors 
the detail of the costing approach to be found in the InEK Kalkulationshandbuch 
(DKG, 2007) used in Germany. We map an example of this approach in Table 4.4.
This properly reflects an activity-based approach because it shifts from treating 
the operating theatre as a single, departmental-based cost pool to one in which 
the operating theatre is understood as a location where many different (and 
separately costed) activities take place, each of which draws on particular subsets 
of resources. As discussed in Section 4.2, once these activities are identified, the 
next step is to understand what drives the cost incurred in carrying them out.
Table 4.4 shows how for each activity a relationship between the activity and 
the consumed resources is established, depending on the practicalities of data 
collection. In some cases, this leads to charging a standard rate, for example, for 
preparing the theatre. In other cases, the consumed resources are related to an 
activity on the basis of a cost driver, such as time. Anaesthetic drugs, for exam-
ple, are charged on the basis of the length of time the patient is anaesthetized. 
The data for the time when anaesthetized are available in the system and can be 
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retrieved easily. Costs for nurses take into account the number of nurses present, 
which can also be captured in the system. However, as it is too complicated to 
include the actual staff cost for each particular nurse, a standard charge rate is 
applied for each nurse. For senior clinicians, the actual staff cost is assigned to 
the session, while for juniors it is again a standard charge rate.
In this last model, the cost objects are again patients. In contrast to the simple 
and intermediate costing models, however, this activity-based model identifies 
the activities in the operating theatre and cost drivers for each activity with 
considerably more granularity. Therefore, it produces more accurate costs than 
the simple and intermediate model. This is important, for example, when set-
ting tariffs and represents a significant improvement in accuracy when using 
actual patient costs to do DRG costing. Another equally, if not more, important 
benefit is in terms of the enhanced opportunities this kind of granular informa-
tion offers for managers who are considering the efficiency and effectiveness of 
clinical activities.
Table 4.4 Much more granular costing of operating theatre activity
RESOURCES Nurses Clinicians Technicians Drugs Transplants Other consumables
ACTIVITIES
Preparing 
the 
operating 
theatre
Cost per 
minute 
(standard 
rate)
Cost per 
minute
Costs per 
minute
Itemized list of 
consumables
Anaesthetic 
activity
Cost per 
minute of 
nurse time
Cost per 
minute
Amount 
of drugs 
consumed
Itemized list of 
consumables
Operation
Skin-to-
knife time 
(standard 
rate)
Cost per 
minute 
based on 
skin-to-
knife time
Cost per 
minute 
based on 
skin-to-knife 
time
Amount 
of drugs 
consumed
Costs for 
specific 
transplant
Itemized list of 
consumables
Clean 
up after 
theatre use
Cost per 
minute 
(standard 
rate)
Itemized list of 
consumables
Recovery of 
the patient
Cost per 
minute 
(standard 
rate)
Itemized list of 
consumables
Source: Based on DKG (2007), p. 239.
Note: Empty cells reflect an activity for which a resource is not used.
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4.3.2 Tracing estate costs through to patients
In the preceding discussion, we largely focused on a range of resources and 
activities that were relatively easily linked to patient activity. A significant por-
tion of organizational costs is made up of indirect costs (overheads, support, 
infrastructure), which are more complicated to link to patients. In this section, we 
present the additional challenges of dealing with these kinds of costs in terms of 
granularity of cost system design taking the example of estate or property costs.
Perhaps the simplest way to deal with estate costs would be to adopt a minimum 
granularity, a top-down, volume-based approach. Such an approach would divide 
the total estate costs across the number of departments (service lines, points of 
delivery), and then from there allocate costs onto patients within each of those 
service lines. This is not likely to be particularly accurate, but the costs of such 
an approach to costing are low. The most obvious cost driver here, and what 
is mandated in many jurisdictions in their costing guidance, is to use a space 
measure, such as square metres of space occupied, as the basis to attribute estate 
costs to cost centres/service lines.
However, there is considerable variability in the level of guidance in different 
jurisdictions with regard to the level of granularity with which this broad approach 
is to be applied. As a result, the treatment of property costs across organizations 
can be irregular. The model shown in Table 4.5 would be the simplest possible 
that is still consistent with the regulation.
Table 4.5 A very simple costing approach for property overheads
RESOURCES All costs
DEPARTMENTS
All departments Square metres
A more granular approach is shown in Table 4.6; here, variation that is cost 
driven by different space use starts to become apparent.
Table 4.6 Beginning to distinguish cost behaviour in more detail
RESOURCES Rent / light / heating Cleaning / infection control
DEPARTMENTS
Medical Square metres Square metres
Administrative Square metres Square metres
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The question remains, however, of how to link property costs to actual patients. 
If estate costs at the cost centre or service line level (for example, in the operating 
theatre) are divided by the number of operations or patients, it will correspond to 
a top-down, volume-based costing approach. Even if the first step was a bottom-
up, activity-based costing approach, through this second step, the calculation 
turns into a top-down, volume-based calculation. If, however, property costs are 
attributed to patients based on minutes spent in the operating theatre, it remains 
a bottom-up, activity-based costing.
Table 4.7 shows the bottom-up, activity-based approach used to account for estate 
costs in the German costing standards. As a first step, estate costs are accounted 
for on a specified indirect cost centre (department). Then, the costs for services 
between cost centres are calculated. Property costs are attributed to cost centres 
according to square metres of used surface. Then, estate costs are allocated in a 
last step from direct cost centres to patients on the basis of activity cost drivers. 
Through these activity cost drivers, a kind of cause-and-effect relationship between 
estate costs and patient is established. The level of granularity underpinning this 
calculation (for example, separating clinical estate costs from administrative estate 
costs and disaggregating estate costs according to each clinical area) affects the 
ability to accurately explain variations in patient costs.
Table 4.7 List of cost drivers to link estate costs with patients in the German 
costing standards for providers informing the tariff
RESOURCES Property costs traced to department
DEPARTMENT 
PROCESSES
Ward Days of care
ICU Hours of intensive care
Dialysis Weighted dialysis according to different kinds of dialysis
Operating theatre Knife-to-skin time with set-up time
Anaesthesia Time of anaesthesia: taking over of the patient with set-up
Delivery room Time of the patient in delivery room
Endoscopic 
diagnostics
Time of intervention (points according to the service catalogue)
Radiology Points according to the service catalogue
Laboratory Points according to the service catalogue
Other diagnostic and 
therapeutic areas
Points according to the service catalogue
Source: Based on DKG (2007), p. 239.
Note: ICU = intensive care unit.
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4.3.3  Hybrid cost systems in practice
Given the variety of costing methods and the wide range of possible levels of 
granularity discussed, the question arises as to what best practice of costing in 
health care is. This question can be answered by considering the ultimate objective 
of clinical costing from a management point of view: to make costs transparent. 
While in principle this objective can be obtained with all methods, variations 
in patient costs are more easily and accurately identified using an activity-based 
costing approach. Further, activity-based, patient-level information allows for 
more appropriate links between cost and health outcomes, which are essential 
for evaluating services in health care (Kaplan & Witkowski, 2014). However, 
the difficulties (and costs) of achieving activity-based costing are greater than 
for volume-based allocation.
In practice, costing approaches are dominated by regulatory requirements for 
DRGs as a basis for tariff setting; this is subject to widely varied sophistication, 
detail and constancy of guidance internationally. However, given the trade-off 
between the cost of cost analysis and the quality of cost information, it is not 
surprising that, in practice, costing standards and systems usually consist of a 
mixture of different methods (that is, activity- and volume-based).
Based on our analysis, we suggest that rather than label a costing system or 
standards as a whole in terms of being activity-based or volume-based, one 
could calculate the percentage of costs that follow each costing methods. 
Costing standards in the United Kingdom recognize that different costing 
methods exist within costing systems; at the provider level, materiality and 
quality scores (MAQS) are used to rate the quality of cost information based 
on the choice of cost drivers. The closer the cost calculation is to actual 
resource consumption, the higher the score; the choice of cost driver is rated 
as bronze, silver or gold. This enables providers to better understand how their 
costing system functions in a more useful way and to evaluate the quality of 
their cost information.
That said, currently, MAQS primarily focus on the nature of the cost driver, 
devoting far less attention to the construction of the cost pool to which the 
cost driver is applied. As discussed in relation to property costs, there are many 
important choices to be made in this regard, and these significantly affect the 
ability of costing systems to show actual costs, regardless of which cost driver is 
chosen. Given this focus on cost drivers, the MAQS score is currently well placed 
to indicate through a low score that there might be room for improvement in 
the quality of costing data. At higher scores, however, the approach loses the 
ability to discriminate between costing systems that have good cost drivers and 
good cost pools, and those that have good cost drivers but deficiencies in cost 
pool structure.
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4.4 The role of cost data in delivering efficient health 
care
Much of the emphasis in this chapter has been placed on the importance of 
the technical characteristics of costing system design. When designing a cost-
ing system, it is important to maintain a clear understanding of the decisions 
and objectives that the system is there to support. In this section, we review 
in more detail the various ways in which cost data can act as a vital input 
into efforts to measure and manage efficiency at both provider and health 
care system levels.
4.4.1  The role of cost data in system-wide resource allocation 
systems
At the health care system level, cost data feed into major resource allocation 
exercises through tariff systems, and also as the basis of negotiations around 
block contracts and the setting of budget levels between providers and pur-
chasers. However, tariff setting within DRG financing systems is often the 
dominating purpose of costing across countries (Chapman, Kern & Laguecir, 
2014).
Countries with DRG-based financing systems use costing data from providers to 
inform tariff setting, comparisons across providers and efficiency and performance 
assessment at the system level. In contrast to many other industries, detailed 
product or service costing is regulated, collected by government and sometimes 
publicly reported. This raises questions about the process of collecting and using 
such costing data at the system level. In particular, there are important questions 
regarding the stewardship responsibilities of governments and regulators in terms 
of the costing approach (Smith et al., 2008).
Development of a clear conceptual framework and a clear vision of the purpose 
of the costing approach are needed. Part of such a framework must be the link of 
costing with practices that are informed by costing, such as DRG development, 
tariff setting, cost–effectiveness calculations and links with financial accounting 
and IT. The guidance must specify the design of the cost systems, including, for 
example, the structure of cost pools and the cost drivers.
Detailed guidance then allows the standardization of cost data across pro-
viders, which is a major stewardship responsibility. In fact, standardization 
is a condition for tariff setting or comparisons across providers. Further, 
the question of which body or institution designs the guidance and collects 
the data needs to be addressed, as does the organization of the data collec-
tion process. In terms of data collection, we need to consider whether data 
are collected from all providers or whether a sampling approach should be 
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chosen. The question of costs, but also of the representativeness of the cost-
ing data, plays a role in this later consideration. Another crucial question 
that needs to be answered is how to handle information governance (Smith 
et al., 2008). Costing data need to be audited and data quality needs to be 
checked. The quality of the information produced using costing data depends 
on the quality of the raw cost data. Audits and quality checks are therefore 
essential to ensure public trust in information and to ensure a well-informed 
public debate.
Cross-country research suggests that considerable variability remains (Chapman 
et. al., 2013). A growing number of countries that initially opted for a volume-
based allocation model for tariff setting are now moving towards activity-based 
costing. For example, both Ireland and the United Kingdom are currently devel-
oping an activity-based approach to costing at the provider level (Chapman et 
al., 2013). The reason is that while volume-based allocation enables the relatively 
quick calculation of a tariff, the tariff itself and the underlying costs are not con-
sidered relevant or reliable enough (Monitor, 2014b). The perceived inaccuracy 
of volume-based overheads allocation at clinical unit levels can even lead clini-
cians to reject the tariff. Ultimately, volume-based costing is most problematic 
because it limits the potential for cost data to meaningfully inform clinical and 
managerial decision-making.
These limitations become apparent once we shift our attention beyond the 
tariff rates to examine the detail of the various cost elements making up 
the tariff figures. If calculation of these cost elements is based on a volume-
based allocation, the result is the reporting of averages, with no variation in 
costs across patients. However, if the calculation is based on an activity-based 
approach, costs across patients will vary. Table 4.8 shows the detailed costs for 
the German DRG for the revision or replacement of hip joints as an example 
of the level of detail.
What becomes important as the emphasis shifts from tariff setting to inform-
ing clinical and managerial decision-making, however, is the costing approach 
adopted in arriving at these various cost elements. In the case of volume-based 
allocations, patients are attributed an average cost for each cost category (for 
example, physician, nurse, ward and overhead costs). This means that there 
is very little variation in reported costs at the patient level. The difference 
in reported patient costs may be explained by just a couple of key drivers, 
such as variation in length of stay or variation in time in the operating 
theatre, for example, with many other sources of variation of actual costs 
left unknown. This becomes problematic when seeking to link costs with 
health outcomes and using costs to make decisions on service redesign, as 
discussed further on.
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Table 4.8 Tariff in the German DRG for revision or replacement of hip joint
Source: InEK (2010).
Note: DRG = diagnosis-related group.
COST-ELEM
EN
T GROUPS
Labour
M
aterial
Infrastructure
German DRG catalogue 
 
I47B 
 
Revision or replacement of hip joint without 
complicating diagnosis, arthrodesis or major 
CC, age >15 years
Physicians
Nursing
Medical/technical staff
General drugs
Individual drugs
Implants and grafts
Material (without drugs, 
implants and grafts)
Individual material (actual 
consumption, without drugs, 
implants/grafts)
Medical infrastructure
Non- medical infrastructure
1
2
3
4a
4b
5
6a
6b
7
8
Total
Cost-centre groups
Units with 
beds
1: Norm
al w
ard
345.04
863.19
46.95
75.72
4.87
–
72.41
7.16
171.25
806.71
2393.30
2: Intensive care unit
35.53
94.54
6.07
12.60
0.61
0.00
15.93
0.71
11.22
44.36
221.56
3: Dialysis unit
0.00
0.00
0.00
0.00
0.00
–
0.00
0.00
0.00
0.00
0.00
Diagnostics and treatments
4: Operating theatre
351.15
–
224.70
15.86
6.36
1363.53
174.88
62.48
136.39
205.65
2541.01
5: Anaesthesia
204.47
–
130.68
18.55
0.63
–
47.91
1.80
24.18
67.11
495.32
6: M
aternity room
0.00
–
0.00
0.00
0.00
–
0.00
0.00
0.00
0.00
0.00
7: Cardiac diagnostics/therapy
0.17
–
0.16
0.00
0.00
0.03
0.04
0.06
0.03
0.09
0.58
8: Endoscopic diagnostics/therapy
0.43
–
0.53
0.02
0.00
0.00
0.19
0.01
0.19
0.36
1.74
9: Radiology
17.41
–
35.12
0.45
0.02
0.01
8.49
13.89
10.07
24.99
110.45
10: Laboratories
5.81
–
44.89
3.18
40.38
0.00
33.63
20.79
4.65
21.14
174.47
11: Other diagnostics and therapies
16.42
2.06
150.58
1.85
0.01
0.01
10.82
7.40
7.15
68.31
264.60
Total
976.43
959.79
639.68
128.23
52.88
1363.58
364.30
114.30
365.13
1238.72
6203.03
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Activity-based costing of overheads enables reporting of costs at the patient level 
that take into account a wide range of differences in resource consumption (for 
example, the specific size of clinical teams for different procedures, rather than 
an average cost per minute across many procedures). This provides more useful 
information for clinical and managerial decision-making, as variations between 
patients can be captured in terms of their actual resource consumption. The 
resulting tariff may then be a fairer basis for resource allocation. Accurate data 
are crucial, as these funding mechanisms are used by regulators and purchasers 
to incentivize reforms in health care practice and delivery at both provider and 
system levels.
4.5 Cost data and support of local clinical and 
managerial decision-making
The effectiveness of incentives to enhance the efficiency of health care services 
depends on the quality of the cost data. This, in turn, is dependent on a con-
structive engagement between costing and clinicians. Providers will not make the 
necessary investments to obtain quality cost data if the data do not play a role in 
clinicians’ day-to-day decision-making. Furthermore, quality cost information in 
health care is difficult to achieve without active engagement of clinicians in the 
design of the cost system, since they are the ones with the granular knowledge 
of activities that is required to produce robust and reliable cost data in the first 
place. This then sets up a potentially vicious or virtuous circle. If things go badly, 
then poor-quality cost data are largely ignored by clinicians to the extent they 
can manage to do so. If things go well, however, then data on cost variations can 
become an important tool to identify areas for clinical improvements.
Importantly, the process of developing the quality of cost information can 
prompt clinical deliberations and decisions over what represents cost-effective 
health care. The point of costing is not simply to reflect what is going on; more 
ambitiously, it can play a role in thinking about better ways to do things so that 
clinicians can play an active role in generating the maximum health benefits for 
their patients within the resources available to them. Clinicians engage with cost-
ing information through a range of common management accounting practices. 
We discuss the main ones in the following sections.
4.5.1  Targeted cost improvement plans
Cost reduction targets are often initially formulated at national or political 
levels. They then cascade downwards through providers with the production of 
targeted cost improvement plans derived for individual clinical units and depart-
ments. The capabilities of clinical units to respond effectively to such targets 
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depend crucially on the nature and quality of the cost information available. 
As discussed earlier, volume-based allocations tend to lead to average reported 
costs, showing variation only in relation to drivers such as length of stay. Based 
on this, information can relatively easily be produced to highlight some of the 
variance in actual patient costs, for example, showing average highs and lows. 
The challenge is that without an activity-based analysis of cost, such variation 
acts as a largely hypothetical promise that overall costs can be reduced if more 
patients were as cheap as the cheapest. Unfortunately, a volume-based costing 
system offers little insight or support in terms of how to effectively and safely 
achieve this.
An activity-based approach to costing enables cost improvement plans that 
take into account the impact of indirect costs on activities. Certain types of 
overheads may be more linked with certain service lines than with others. 
Rather than advising to cut costs by 10% across all activities, cost manage-
ment can better focus on the specific costs and the specific activities that 
cause excessive costs. Analysed at the patient level, this information can then 
be compared with the health outcomes achieved to inform analysis of both 
efficiency and effectiveness.
An important caveat to the ongoing relevance of targeted cost improvement plans 
is that in the face of continued growth in demand for health care services, it seems 
likely that more attention will need to be given to generating more health from 
existing spending rather than hoping to make significant reductions in current 
spending. This agenda suggests greater attention to the following management 
accounting practices.
4.5.2  Benchmarking
Once cost data are activity-based and linked to health outcomes, benchmarking 
is a powerful way to engage clinicians in exactly the kind of analysis that cost 
improvement plans require. Effective benchmarking builds from discussions with 
physicians about the reasons that costs are higher or lower than those of other 
providers. Discussions between costing experts and clinicians are also essential 
to ensure that cost data appropriately reflect physicians’ practice and resource 
consumption decisions.
Such discussions aim to explain the variation in cost between clinicians and 
patients. In some cases, higher costs are justified by patients requiring more 
complex care. In other cases, differences in costs are caused by differences in 
medical practice. A difference could be caused, for example, by the use of differ-
ent drugs or other consumables, but also by different surgical techniques. Such 
differences, once visible, form the basis of discussions among clinicians aimed at 
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confirming a shared understanding of when variation is appropriate, and align 
diverse clinical practice where evidence shows a clinically determined balance 
of health outcomes and cost.
Discussions around comparisons of costs between the service lines of different 
hospitals can also reveal differences in resource consumption for indirect costs. 
If activity-based costing is in place, decision-makers can then spot more easily 
the origin of such differences and potentially make services more efficient. While 
activity-based costing has been shown to reduce overall costs (see, for example, 
Pizzini, 2006), its main advantage may actually lie in using the existing resources 
more effectively. This is particularly important in a context of coping with rising 
demand without increasing the available resources.
4.5.3 Budgeting
Building on these kinds of analyses, activity-based costing data can go on to 
inform more appropriate budgetary processes as part of the ongoing manage-
ment of providers. When there are no costing data at the patient level, the danger 
is that budgets are set based on past arrangements, power and interests rather 
than clinical needs, practices and outcomes. Activity-based costs at the patient 
level allow for more accurate estimates of costs at the service line-level based on 
the number and type of patients expected. The budget process becomes more 
objective and fair-based on clearly specified modelling of resource consumption 
and less on power and local interests.
Activity-based costing has two main advantages here. It enables the construction 
of the budget in a bottom-up way, enabling the budget holder and operational 
staff to participate in the budget process while having a better understanding 
of the impact of their work processes on the costs entailed. This is supported 
by the use of language that directly speaks to clinical activities as opposed to 
technical accounting terminology. Staff can understand when constructing 
the budget how the costs of work processes, for example, are linked to certain 
overhead costs. Further, it enables a breakdown of the responsibility of budget 
holders to activity levels (that is, budget holders for the different activities can 
be defined). In administrative areas, this can allow a more effective definition 
of responsibilities and cost management.
4.5.4 Service redesign
As has been discussed, activity-based cost information informs a variety 
of conversations that can inform robust decisions regarding the nature of 
how health care services might be more effectively arranged. At its bluntest, 
redesign can take the form of product/service selection decisions, whereby 
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procedures or clinical areas might be dropped altogether, or more optimisti-
cally, improved on.
This kind of decision has become important in many countries at the health 
care system level also, where providers face a restructuring, as there are too 
many providers per patient in certain catchment areas, such as central London. 
Providers are then asked to focus on certain services representing their strengths, 
while competitors may take over those services that are considered a weakness. 
A common tool recommended by Monitor in the United Kingdom, for making 
decisions in such cases, is the portfolio matrix. The portfolio matrix calculates 
the profit/loss per service line and the relative size of the service line for the 
provider (Monitor, 2006). A more sophisticated approach over and above such 
service selection decisions, however, is to use activity-based cost information to 
inform redesign activities so that services become more clinically and economi-
cally beneficial.
4.5.5  Performance management
A popular metric for measuring efficiency is the average length of stay in hospital. 
This offers a simple way to reduce the potentially vast complexity of individual 
patient resource consumption patterns to an easily observed driver of overhead 
costs. However, studies have shown that the length of a hospital stay has limited 
influence on the total costs of a patient stay (Taheri, Butz & Greenfield, 2000). 
Taheri, Butz & Greenfield showed that reducing length of stay by 1 day decreases 
total costs of care by only 3%. They concluded that staff should instead focus on 
process changes and better use of capacity when seeking to improve efficiency. 
This requires delving into the complexities of resource consumption and resource 
spending that measures such as length of stay simplify away from.
More advanced approaches to performance management include the use of 
costing data, activity data and clinical data from a service line, for example, 
taking into account the number of patients treated in a service, costs for certain 
DRGs in that service line and other relevant indicators. Some providers have 
introduced performance indicators based on the balanced scorecard system 
(Kaplan & Norton, 1996). For example, Monitor recommends the use of a 
balanced scorecard at provider and service line levels in the United Kingdom. 
This system is designed to link strategy and performance indicators, by choosing 
those performance indicators that are instrumental for achieving strategic goals.
State-of-the-art performance management systems in health care go a step 
further. They seek to link both economic and clinical performance (Kaplan & 
Porter, 2011). For example, the Healthcare Costing for Value Institute in the 
United Kingdom aims to improve the quality of the costing information in 
Management accounting and efficiency in health services 97
health care, but also to further develop links between costs and outcomes to 
measure values. This again is only meaningful at a patient-level of disaggrega-
tion, and requires both outcome and cost data to demonstrate value (Kaplan 
& Witkowski, 2014).
4.6 Conclusions
In this chapter, we have reviewed the technical characteristics that underlie good-
quality cost data, and some of the ways in which such data can inform efforts 
to measure and enhance the efficiency of health care services. We have argued 
that the main questions for the design of a costing system relate to matters of 
granularity at each of the three steps in costing system design: granularity of 
the resources, granularity of cost pools and granularity of cost objects. It is only 
when resources and cost pools are defined in a sufficiently granular way that an 
activity-based costing approach can be achieved. Shifting away from volume-
based methods is essential if cost information is to accurately reflect resource 
use and play a more direct role in health care management.
Activity-based costing enables the management of indirect costs by virtue of its 
reorganization of cost pools away from traditional (often financial reporting-
driven) structures towards analysis of activities with defined cost drivers. Realizing 
the decision-making benefits of these data also requires that cost pools be mapped 
onto areas of decision-making responsibility. In general, the misalignment of 
cost analysis and decision-making structures risks inhibiting efforts at service 
redesign in the first instance. Such misalignment runs the risk that any savings 
from service redesigns are unlikely to ultimately translate into changes in resource 
spending. While activity-based costing cannot directly inform reductions in 
overall spending, particularly in a setting with a high percentage of fixed costs, it 
can contribute to greater efficiency by indicating where slack exists and thereby 
contribute to increases in outputs. This seems particularly pertinent in health 
care settings where there is likely to be increased demand for services and thus 
expectations of reduced spending seem unrealistic.
Our emphasis in this chapter arises from our sense that cost information is fun-
damental to a wide range of efficiency-oriented practices. Past efforts to clearly 
and consistently conceptualize costing in the health care sector have not been 
strong enough to bring about widespread production and use of costing data that 
can support evidence-based decision-making. We argue that regulators should 
play an essential role in ensuring that resources set aside for the development of 
costing systems are not spent reinventing the wheel. It is essential that costing 
guidance be sufficiently detailed so that costing in practice can deliver on the 
promise to enhance the efficiency of health care provision.
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